scholarly article | Q13442814 |
P356 | DOI | 10.1016/0002-8703(88)90133-0 |
P698 | PubMed publication ID | 2903652 |
P2093 | author name string | J M Herrmann | |
E O Mayer | |||
P433 | issue | 5 Pt 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1416-1421 | |
P577 | publication date | 1988-11-01 | |
P1433 | published in | American Heart Journal | Q2227156 |
P1476 | title | A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors. | |
P478 | volume | 116 |
Q40624637 | A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease |
Q40621879 | Antihypertensive drugs: issues beyond blood pressure control |
Q40953069 | Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris |
Q36676469 | Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease |
Q36482914 | Clinical perspective on celiprolol: Cardioprotective potential |
Q67897406 | Clinical safety and efficacy of celiprolol |
Q72772554 | Effects of celiprolol vs. nifedipine on serum lipoproteins in patients with mild to moderate hypertension |
Q41875844 | Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients |
Q51581362 | Effects of oral albuterol on serum lipids and carbohydrate metabolism in healthy men. |
Q68291248 | Hypertension with concomitant conditions: The changing role of β-adrenoceptor blockade |
Q44431760 | Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. |
Q36482909 | Metabolic considerations in the choice of therapy for the patient with hypertension |
Q40923118 | New approaches to the prevention of atherosclerosis |
Q41560071 | Pharmacological approaches and strategies for therapeutic modulation of fibrinogen |
Q68292780 | The effects of cardioselective vasodilating β-blockers on lipids |
Q37119116 | The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients |
Q71618741 | Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension |
Search more.